Ancora Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-531
Closed -$12K 2135
2026
Q1
$12K Buy
531
+515
+3,219% +$11.8K ﹤0.01% 1728
2025
Q4
$381 Buy
+16
New +$398 ﹤0.01% 2332
2023
Q3
Sell
-600
Closed -$14.4K 1793
2023
Q2
$14.4K Hold
600
﹤0.01% 1204
2023
Q1
$12.8K Hold
600
﹤0.01% 1225
2022
Q4
$10K Hold
600
﹤0.01% 1330
2022
Q3
$8K Hold
600
﹤0.01% 1533
2022
Q2
$15K Sell
600
-209
-26% -$6.25K ﹤0.01% 1503
2022
Q1
$27K Hold
809
﹤0.01% 1462
2021
Q4
$26K Hold
809
﹤0.01% 1494
2021
Q3
$28K Buy
809
+209
+35% +$8.16K ﹤0.01% 1377
2021
Q2
$25K Hold
600
﹤0.01% 1288
2021
Q1
$22K Hold
600
﹤0.01% 1276
2020
Q4
$25K Hold
600
﹤0.01% 1027
2020
Q3
$25K Hold
600
﹤0.01% 983
2020
Q2
$26K Hold
600
﹤0.01% 941
2020
Q1
$20K Hold
600
﹤0.01% 1048
2019
Q4
$22K Buy
+600
New +$21.3K ﹤0.01% 1048
2018
Q4
Sell
-600
Closed -$31K 813
2018
Q3
$31K Buy
+600
New +$30K ﹤0.01% 989
2017
Q1
Sell
-1,800
Closed -$76K 772
2016
Q4
$76K Buy
+1,800
New +$73.4K 0.01% 708

Other funds holding FMS

Ancora Advisors's FMS Position: Q2 2026 in Review

Ancora Advisors sold out of Fresenius Medical Care (FMS) in Q2 2026, closing a stake of 531 shares — an estimated $12K sold.

Ancora Advisors first reported a position in FMS in Q4 2016 and held it in 19 quarters. The position peaked at $76K in Q4 2016. 235 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Ancora Advisors reported no remaining Fresenius Medical Care position as of Q2 2026 after selling out during the quarter.
  • Ancora Advisors sold 531 Fresenius Medical Care shares in Q2 2026, an estimated $12K.
  • Ancora Advisors first reported a position in Fresenius Medical Care in Q4 2016 and held it in 19 quarters.
  • Ancora Advisors's Fresenius Medical Care position peaked at $76K in Q4 2016.
  • 235 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.